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Background: Recommended vector control tools against malaria, such as long-lasting insecticidal nets (LLINs) and
indoor residual spraying (IRS), mainly target mosquitoes that rest and feed on human hosts indoors. However, in
some malaria-endemic areas, such as Southeast Asia and South America, malaria vectors primarily bite outdoors
meaning that LLINs and IRS may be less effective. In these situations the use of topical insect repellents may reduce
outdoor biting and morbidity from malaria. A systematic review and meta-analysis was conducted to assess the
efficacy of topical insect repellents against malaria.
Methods: Studies were identified using database searches (MEDLINE, EMBASE, Web of Science and clinical trials
registers), as well as reference list searches and contact with researchers. Randomized and non-randomized controlled
trials were included that assessed the effect of topical repellents (all active ingredients and concentrations) on
Plasmodium falciparum or Plasmodium vivax malaria or infection in malaria-endemic populations. Meta-analysis
of clinical data was conducted in order to generate summary risk ratios.
Results: Ten trials met the inclusion criteria. Studies varied in terms of repellent active ingredient and formulation,
co-interventions, study population, compliance, and follow-up period. Topical repellents showed an 18% protective
efficacy against P. falciparum malaria, although this was not significant (95% CI: -8%, 38%). Similarly, the average
protective efficacy of topical repellents against P. vivax malaria did not reach significance (protective efficacy: 20%,
95% CI: -37%, 53%). Exclusion of non-randomized trials from the meta-analysis did not alter the findings.
Conclusions: Although topical repellents can provide individual protection against mosquitoes, the results of this
meta-analysis indicate that topical repellents are unlikely to provide effective protection against malaria. However, there
was substantial heterogeneity between studies included and the relatively small number of studies meant that this
heterogeneity could not be fully explored in the analysis. Further well-designed trials of topical repellents at appropriate
doses and alternative modes of repellent delivery, such as spatial repellents and long-lasting insecticide-treated
clothing, are required.Background
Malaria is a major cause of morbidity and mortality in
developing countries. In 2012, the World Health Organ-
ization (WHO) estimated that there were 207 million
cases of malaria, which caused approximately 627,000
malaria deaths [1]. The parasites that cause malaria, primar-
ily Plasmodium falciparum and Plasmodium vivax, are
transmitted by the bite of female mosquitoes belonging to* Correspondence: anne.wilson@durham.ac.uk
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malaria control and recommended vector control tools
include long-lasting insecticidal nets (LLINs) and indoor
residual spraying (IRS). Both tools have contributed to the
large declines in malaria observed over the past decade. It
is therefore of great concern that insecticide resistance in
malaria vectors is widespread in sub-Saharan Africa (SSA),
particularly to pyrethroids, the only insecticide class suit-
able for impregnation of LLINs [2].
Both LLINs and IRS aim to control malaria vectors
that feed on human hosts and rest indoors. However, in
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example, the most important malaria vectors in the
Greater Mekong Subregion in Southeast Asia are Anoph-
eles dirus, Anopheles minimus and Anopheles maculatus
which often bite outdoors and prior to 22.00 hours before
people who own LLINs are protected by them [3,4]. Scale
up of LLINs in SSA has been associated with a change in
vector dominance from the predominantly indoor biting
vector Anopheles gambiae s.s. to the outdoor biting vector
Anopheles arabiensis [5-7]. There is also evidence of
behavioural resistance of malaria vectors in response to
the wide-scale use of IRS and LLINs [8]. Malaria vectors
may be adapting their behaviour to early evening and
dawn biting in response to reduced availability of blood
meals at night when people are sleeping under LLINs.
Indeed, studies in SSA [6,9] and the Pacific [10,11] have
reported an increase in early evening biting of malaria
vectors following roll-out of LLINs or IRS. Increasing
development of urban areas and availability of electricity
means that people are staying awake for longer and are
exposed to outdoor-biting mosquitoes in the evening
[12]. In addition, some populations groups, for example
hunters, rubber tappers or forest workers that are active at
night or sleep in the forest [13,14] are at high risk of
malaria transmission from outdoor-biting mosquitoes.
Based on this information, there is a need for vector con-
trol tools to protect people against outdoor-biting vectors.
Topical insect repellents protect users from mosquito
bites as people go about their daily activities and therefore
offer a potential tool against outdoor-biting mosquitoes. It
is likely that people have been using repellents to prevent
insect bites since prehistory [15]. Early repellents were
largely plant derived and include some repellents that
are still in use today, such as citronella (oil derived from
plants of the Cymbopogon genus), neem (leaves from
Azidarachta indica) and lemon eucalyptus (Eucalyptus
maculata citriodon). N,N-diethyl-m-toluamide (DEET),
developed in the 1950s, is the most effective repellent
available [16]. Topical insect repellents are very successful
at reducing outdoor biting at any time of the day from a
wide range of insects, but this protection is short-lived.
For example, the current ‘gold standard’ repellent, DEET,
applied topically will provide approximately six hours
of protection under field conditions, although this is
dependent on the formulation [17,18].
A number of trials of topical repellents against malaria
have been conducted but it is necessary to synthesize
the results of these trials in order to inform policy deci-
sions on use of topical repellents. Narrative and systematic
reviews of topical insect repellents for personal protection
have been conducted but these did not use meta-analysis
[19-21]. Therefore, a systematic review and meta-analysis
of randomized and non-randomized controlled trials was
conducted to determine the efficacy of topical insectrepellents against P. falciparum and P. vivax malaria or
infection in malaria-endemic populations.
Methods
Literature search
Recommendations made by the Preferred Reporting Items
for Systematic Reviews and Meta-Analyses (PRISMA)
group were followed where possible [22,23] (PRISMA
Checklist: Additional file 1).
A systematic search of the literature was performed in
January 2014 and updated in July 2014. Medline (1946-),
Embase (1980-) and Web of Science databases were
searched using search terms including ‘malaria’ and ‘insect
repellents’ and using MeSH terms where appropriate. No
language restrictions were placed on this search. More
detail on the search strategy is given in Additional file 2.
In addition, clinical trials databases [24,25] were searched,
reference lists of identified manuscripts were checked and
researchers were contacted to identify ongoing studies.
ALW screened the abstracts of the citations identified for
potentially relevant studies and full text documents were
obtained for those publications deemed to be relevant. The
articles were scrutinized to ensure that multiple publica-
tions from the same study were included only once.
Study inclusion and exclusion criteria
Studies identified were assessed against inclusion and
exclusion criteria by ALW and SWL. Randomized and
non-randomized controlled trials of topical repellents in
endemic populations were included. Trial interventions
included any topical insect repellent, regardless of active
ingredient or concentration used. Studies including co-
interventions (usually insecticide-treated nets (ITNs) or
LLINs) were included. Control arms received either no
repellent, placebo repellent or co-interventions. Studies
were included if they assessed the efficacy of topical
repellents against either P. falciparum or P. vivax mal-
aria cases or infection (self-reported or diagnostically
confirmed using microscopy or a rapid diagnostic test).
Both incidence and prevalence measures were included.
Studies in travellers to malaria-endemic regions were
excluded since the susceptibility of these populations
to malaria and other factors, such as trial duration and
compliance, would likely differ. Studies of insect
repellent impregnated clothing and spatial repellents
were also excluded. Studies assessing only entomo-
logical outcomes and arm-in-cage/laboratory studies/
semi-field studies were excluded since the focus was
primarily on determining whether repellents impacted
on malaria morbidity.
Data extraction and analysis
ALW and VC-H independently extracted data from
included studies into a standardized form capturing data
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ing methods, repellent formulation, estimated coverage
or compliance and method of estimation, type of con-
trol, co-interventions, outcome measures, and length of
follow-up from each trial. If these were not presented
in the report, the trial location was used to find mal-
aria endemicity, Plasmodium species and Anopheles
vectors present. Where the Plasmodium species was
not determined, the protective efficacy was attributed
to the most common Plasmodium species which
was identified either from the manuscript or expert
opinion.
Clinical outcomes were reported as either risks, odds
or rates of disease or infection in the published papers.
For consistency across studies, risks of disease or infection
were used in the meta-analysis. In the few cases where
studies reported rates, risks were calculated using data on
the number of cases and size of the study populations
which was included in the published papers. The meta-
analysis was conducted using unadjusted data. This
decision was taken due to the small number of trials
identified that reported adjusted effect estimates and
the inconsistency across measures reported (adjusted
rate and odds ratios). The metan command was used to
perform meta-analysis in Stata 13 (StataCorp, Texas,
USA). Due to the higher risk of bias in studies that
were non-randomized, the meta-analysis was conducted
both including and excluding these studies. Statistical
heterogeneity was assessed using a χ2 test. Due to the
small number of studies in each comparison, the data
were said to be heterogeneous if the χ2 test p value was
less than or equal to 0.1 [26]. The I2 statistic was used to
quantify the degree of heterogeneity. I2 was calculated as
I2 = ((Q - d.f.)/Q) x 100%, where Q is the χ2 statistic and d.
f. is the number of degrees of freedom. Due to the high
levels of statistical heterogeneity found and the a priori
assessment that the studies were indeed heterogeneous
(different repellent types, study sites, etc.), the summary
effect measure was calculated using random effect meta-
analysis, rather than fixed effect meta-analysis. Protective
efficacy (PE) was calculated as PE =1− (risk ratio of clin-
ical disease or infection during the intervention period) ×
100%. PE (or relative risk reduction) can be interpreted
as the percentage reduction in risk of clinical disease or
infection associated with the intervention. A standard
formula was used to calculate 95% confidence intervals
for risk ratios [27].Risk of bias assessment
ALW assessed the risk of bias in the studies using the
Effective Practice and Organization of Care (EPOC) risk
of bias assessment form [28]. Risk of bias for each of the
domains was graded as low, high or unclear risk.Results
Study selection
The initial systematic literature search identified 1,736
unique records (Figure 1). 1,699 records were excluded
based on review of the title and abstract. The majority of
these studies related to use of insecticide treated mate-
rials (e.g. LLINs) or chemoprophylaxis in travellers, or
described risk factors for malaria. 37 full text records
were reviewed and of these eight studies met the inclu-
sion/exclusion criteria. Contact with experts identified one
additional study [12]. The update of the search in July
2014 identified two additional studies – one of which was
published [29]. The second study was identified from
Clinicaltrials.gov [24] (Identifier: NCT01663831) and
could not be included because the data were still being
analysed. Therefore, the total number of studies included
in the review was ten. One of these studies was available
as a study report [12] but was later published as a peer-
reviewed manuscript [30]. Figures from that manuscript
were used for the analysis.
Study characteristics and risk of bias
The ten studies identified were conducted in Africa
(Ethiopia, Ghana, Tanzania), Asia (India, Lao People’s
Democratic Republic (PDR), Pakistan, Thailand) and South
America (Bolivia and Ecuador and Peru) (Additional file 3).
Three studies assessed the effect of repellents on P.
falciparum malaria/infection [30-32], five studies assessed
the effect on both P. falciparum and P. vivax malaria/
infection [29,33-36] and two studies did not determine
the Plasmodium species [37,38]. Four studies measured
malaria incidence [30,32,37,38], four studies measured
incidence of infection [33-36] and two measured parasite
prevalence [29,31]. Studies utilized a range of topical
insect repellents, the most common being DEET and four
of the ten studies used ITNs or LLINs as a co-
intervention. The study characteristics of these trials are
summarized in Additional file 3.
Risk of bias assessment found that studies were gener-
ally at low risk of bias, although poor description in the
published papers meant that many parameters could
only be classified as ‘unclear’ (Additional file 4). Seven
studies were reported as being randomized trials (although
the randomization process was not well described in
several papers), and it was assumed that three trials mak-
ing no mention of randomization were non-randomized
[31,32,38]. In one of these studies by Vittal et al., baseline
malaria incidence was significantly lower in the interven-
tion group compared to control group [38], and in
another by Dadzie et al. baseline malaria prevalence was
significantly greater in the intervention village at baseline,
although this would most likely serve to bias the effect size
downwards [31]. The study in Tanzania reported that
socio-economic status was higher in the control arm,
Figure 1 Flow chart of study selection (adapted from [22]).
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one study identified [37] did not use diagnostic confirm-
ation of malaria, instead relying on self-reporting which
the researchers ‘validated’. This study reported that agree-
ment between self- and professional-diagnosis (including
diagnostic confirmation) was 80-90%.
Results of individual studies
Of the nine studies that assessed the efficacy of topical
repellents against P. falciparum malaria, only one of
these by Rowland et al. reported a significant protective
efficacy [35]. Only one of the seven studies that assessed
the efficacy of topical repellents against P. vivax malaria
reported a significant protective efficacy [33]. Individual
study results are reported in Tables 1 and 2 and further
detail is given in Additional file 5.
Synthesis of results
Two studies could not be included in the meta-analysis.
The trial conducted by Kroeger et al. in Ecuador and
Peru did not report numbers of cases or denominators[37]. This was also the only study included which relied
on self-reported malaria incidence. Dutta et al. seemed
to misinterpret the results of their study in the published
paper stating that risk ratios greater than 1 were protect-
ive [32]. Attempts to contact the authors to clarify and
obtain the study data were unsuccessful and so this
study was excluded from the meta-analysis.
The combined summary risk ratio for the effect of
topical repellents on P. falciparum malaria or infec-
tion was 0.82 (95% CI: 0.62, 1.08, p = 0.2) (Figure 2).
There was substantial heterogeneity across studies
(χ 2 p value = 0.01, I2 = 62%). Similarly the protective
efficacy of topical repellents against P. vivax malaria
or infection was not significant (risk ratio: 0.80 (95%
CI: 0.47, 1.37, p = 0.4) (Figure 3). There was consider-
able heterogeneity across studies (χ2 p value <0.001,
I2 = 87%). When non-randomized trials were excluded
from the meta-analysis, the risk ratios did not change
substantially (P. falciparum risk ratio: 0.76, 95%CI:
0.55, 1.03, p = 0.08, P. vivax risk ratio: 0.76, 95%CI:
0.42, 1.39, p = 0.4).
Table 1 Efficacy of topical repellents against Plasmodium falciparum
Study Repellent Control Risk ratio (95%
confidence intervals)Cases Population at risk Cases Population at risk
Chen-Hussey et al. [34] 35 3,947 33 3,961 1.06 (0. 66-1.71)
Dadzie et al. [31] 54 205 47 204 1.14 (0.81-1.61)
Deressa et al.1 [29] 23 2,399 19 2,273 1.15 (0.63 - 2.10)
Dutta et al. [32] - - - Yr 1: 1.16 (0.85-1.58)
Yr 2: 1.20 (0.83-1.72)
Hill et al. [33] 1 2,041 6 1,967 0.16 (0.02-1.33)
Kroeger et al.2 [37] 8.5% 6.7% 1.273
McGready et al.4 [36] 40 379 30 202 0.71 (0.46-1.11)
Sangoro et al.5 [30] 115 2,224 137 2,202 0.83 (0.65-1.06)
Rowland et al. [35] 23 618 47 530 0.42 (0.26-0.68)
1Denominator is average of two follow up surveys, number of infections is combined total from two follow-up surveys - based on assumption that infections at
2-month time point were new infections (1 month between follow-up surveys); 2Trial conducted in two sites. This data is from Ecuador where according to
manuscript 86% of cases were usually due to P. falciparum. Since parasite species of cases was not determined, these cases were attributing to P. falciparum;
3Counts and denominators not reported in manuscript so unable to calculate 95% confidence intervals; 4Cases and denominator back-calculated from percentages and
confidence intervals reported in paper; 5number of cases/denominator taken from published manuscript not study report.
Wilson et al. Malaria Journal 2014, 13:446 Page 5 of 9
http://www.malariajournal.com/content/13/1/446Discussion
This meta-analysis did not show a significant protective
effect of topical repellents against either P. falciparum
(18%, 95% CI: -8%, 38%) or P. vivax malaria or infection
(20%, 95% CI: -37%, 53%). Calculating the summary
effect measure excluding non-randomized trials, did not
alter the conclusion – no significant protective effect of
topical repellents was observed.
Heterogeneity was high in the meta-analysis indicating
substantial variance between the studies. Sources of het-
erogeneity included varying background rates of malaria,
outcome measures (malaria cases or infection), follow-up
periods, characteristics of participants (e.g., age), active in-
gredients, concentration and formulation of the repellent,
user compliance, and co-interventions. Due to the small
number of studies identified it was not possible to conduct
subgroup analysis to account for some of these important
differences between studies. The most obvious differenceTable 2 Efficacy of topical repellents against Plasmodium viva
Study Repellent
Cases Population at risk
Chen-Hussey et al. [34] 14 3,947
Deressa et al. 1 [29] 21 2,399
Hill et al. [33] 14 2,041
Kroeger et al. 2 [37] 17.9%
McGready et al. 4 [36] 67 316
Rowland et al. [35] 103 618
Vittal et al. 5 [38] 8 228
1Denominator is average of two follow up surveys, number of infections is combine
2-month time point were new infections (1 month between follow-up surveys); 2Trial c
of cases were usually due to P. vivax. Since parasite species of cases was not determin
reported in manuscript so unable to calculate 95% confidence intervals; 4Cases and de
paper; 5Number of cases is combined total from two years of follow up.was in study location, which would lead to varying back-
ground malaria rates. The interventions also varied; DEET,
permethrin and p-Menthane-3,8-diol (PMD) were all used
at different concentrations and formulations. Compliance
varied greatly between studies from 58% in Lao PDR to
98% in Bolivia.
There is strong evidence from a large number of studies
that topical repellents protect from mosquito bites
[39-44]. Studies included in the review also demonstrated
high protection of the repellents against mosquito bites.
For example, Moore et al. reported a high level of protec-
tion from An. gambiae s.l. biting in a field trial using
human-landing catches in Tanzania [12] and Dadzie et al.
reported that the biting pressure of Anopheles on unpro-
tected individuals averaged 86 bites/man/night, which was
significantly reduced to nine bites/person/night among
collectors using the NO MAS repellent [31]. However, the
results of this meta-analysis suggest that protection fromx
Control Risk ratio (95%
confidence intervals)Cases Population at risk
16 3,961 0.88 (0.43-1.80)
17 2,273 1.17 (0.62 - 2.21)
66 1,967 0.20 (0.12-0.36)
24.1% 0.743
70 266 0.81 (0.60-1.08)
62 530 1.42 (1.06-1.91)
13 411 1.11 (0.47-2.64)
d total from two follow-up surveys - based on assumption that infections at
onducted in two sites. This data is from Peru where according to manuscript 86%
ed, these cases were attributing to P. vivax; 3Counts and denominators not
nominator back-calculated from percentages and confidence intervals reported in
Figure 2 Forest plot showing risk ratios and summary effect estimate of topical insect repellent against Plasmodium falciparum
malaria (random effects meta-analysis).
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translate into protective efficacy against clinical malaria.
There are a number of potential reasons for this that
are discussed briefly here. Firstly, compliance with
repellent use may be suboptimal and vary amongst the
study population. A mathematical model developed by
Kiszewskia and Darling indicates that the probability of
avoiding infections is highly sensitive to small changes
in compliance and product efficacy – both of which are
exponential parameters in the model [45]. In a study
setting, compliance is difficult to measure as direct
observation is only practicable in a small number ofFigure 3 Forest plot showing risk ratios and summary effect estimate
(random effects meta-analysis).participants. Most of the trials used a combination of
self-reported data confirmed by a small number of
direct observations. Self-reported data may be unreliable
due to courtesy bias whereby participants report using
repellent even though they have not used it. It is also diffi-
cult to standardize repellent use given that participants
may use varying amounts of the lotion each time they
apply it leading to varying repellent effects. Secondly, the
duration of protection from biting provided by repellents
is relatively short. Even though participants may apply the
lotion correctly in early evening, waning of the effect of
the repellent may mean that participants are unprotectedof topical insect repellent against Plasmodium vivax malaria
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may be even greater if the participant perceives they are
protected and so does not comply with use of personal
protective measures, such as LLINs. Thirdly, in some of
the studies LLINs were used as a co-intervention – in-
deed, it is unethical to deny LLINs from control groups
since they are considered ‘standard best practice’. How-
ever, this means that the study needs to show an effect of
repellents on top of LLINs, an already highly effective
intervention. This poses a problem of ‘statistical power,
and the law of diminishing returns’ as noted by Lines and
Kleinschmidt [46], whereby large sample sizes are required
to have sufficient power to show a small increase in pro-
tection on top of LLINs. Lack of power may have been a
problem in some of the studies. For example, in Thailand
[36] and Tanzania [12,30] reductions in malaria rates were
recorded in repellent users, but the lower than expected
overall malaria rates meant that sample sizes were too low
for this reduction to reach significance.
Compliance with preventive measures such as topical
repellents is dependent on a number of factors including
acceptability of the product and biting nuisance. Ensuring
high compliance with repellent use is critical in order to
prevent diversion of malaria vectors to non-repellent-using
individuals, especially if the vector species are strongly
anthropophilic. A study in Tanzania showed that placebo
users living in a village where 80% of the households used
15% DEET had over four times more mosquitoes resting in
their dwellings in comparison to households in a village
where nobody used repellent [47]. Some of the better
designed studies included in this review attempted to
reduce this diversion effect by enrolling a relatively
small proportion of the population from villages/camps
[12,34,35], but this was not the case with all studies or
was not described in the papers.
This review assessed the efficacy of topical insect
repellents against malaria in endemic populations but
did not look at their efficacy when used by travellers.
Malaria risk (due to for example immunity or living
accommodation) and repellent use is likely to be different
in endemic populations and travellers and so the data
cannot be extrapolated between these two populations.
Since topical repellents are able to reduce biting rates
when used correctly [42], it is recommended that travel-
lers continue to use them [20,48,49].
This review has a number of limitations which should
be noted. Firstly, despite a comprehensive literature search
of several databases, clinical trials registers and contact
with researchers there is a possibility of missing some rele-
vant studies. However, although a systematic search of
grey literature databases was not conducted it is likely that
all relevant studies were identified. While ten studies
might be considered modest in order to make conclusions
on a vector control tool, this is comparable to othersystematic reviews of vector control tools (Cochrane
reviews on ITNs =22 studies [50], IRS = six studies [51],
larvivorous fish =12 studies [52], larval source manage-
ment =13 studies [53]). Studies were generally at low
risk of bias, although many bias parameters could only
be rated as ‘unclear’ given the poor reporting in the
published studies. Efforts should be made to improve
reporting of vector control studies.
Conclusions
Although entomological evidence is available that topical
repellents protect individuals from mosquito bites, the
results of this meta-analysis suggest they are ineffective
at preventing malaria morbidity. However, there was
substantial heterogeneity between studies and the rela-
tively small number of studies identified meant that the
effect of this heterogeneity on the summary effect estimate
could not be assessed. Therefore it is recommended that
further well-designed trials of topical repellents at appro-
priate doses be conducted. Additionally, research should
focus on alternative modes of repellent delivery such as
spatial repellents and long-lasting insecticide-treated
clothing, which rely less on compliance. Although repel-
lents do not seem to be effective against malaria, they may
be effective against other diseases vectored by insects,
including dengue and leishmaniasis [54]. Studies of topical
repellents against other vector-borne diseases should
therefore be conducted.
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